1. Cardiovascular and Metabolic Diseases; Innovative Medicines and Early Development Biotech Unit; AstraZeneca; Mölndal Sweden
2. Department of Neuroscience; Physiology and Pharmacology; University College London; London UK
3. Department of Physiology and Neuroscience; University of Gothenburg; Gothenburg Sweden
4. Centre for Nephrology; University College London; London UK